You’re the Superhero.
MammoScreen is Your Sidekick!
Learn how MammoScreen® can help you in breast
cancer detection.
FDA cleared for both Global AI Winner
2D and 3D screenings Over 1,100 participants
Actionable Scoring.
Accurate Indications.
MammoScreen delivers a unique score that is
easier to read and understand than any other AI for
mammography screening available. On a scale of 1-10
and colored green, yellow, red, we identify findings and
rank them by level of suspicion.
• If it is green (1-4), approximately 75% of all screenings,
the marks aren’t displayed by default, thus not
cluttering your screen.
• If the finding is red (7-10), MammoScreen is confident
that this is an area of concern and likely cancerous.
• If the mark is yellow (5-6), the software has identified
something suspicious, and is alerting you to review for
your expert opinion.
No other AI software delivers such a complete,
easy-to-read, and understandable scoring system.
Get rapidly confident in the AI output and
read faster!
MammoScreen is the only AI available that can
incorporate priors into consideration.
With the goal of helping radiologists even further,
MammoScreen can incorporate priors into consideration
for the evaluation of screenings. This helps you confirm
your findings and makes the software even more
confident, effective, and intelligent*.
Reviewing prior images, MammoScreen identified cancer up to two years earlier than diagnosis.
This is one example of a case where the mass was discovered two years prior.
In review of prior cases, MammoScreen was able
to identify 21% of cancer up to two years before
diagnosis**. This means that if MammoScreen had been
used during those screenings, cancer could have been
found earlier.
MammoScreen provides confidence and can help
lead to improving cancer detection rate.
*S.Pacilè, J. Guillaumin, P. FIllard (2021, Nov 28 - Dec 2). Reducing false-positive recalls by adding temporal changes information to an AI system for breast
cancer detection [conference presentation]. RSNA 2021
**J. Lopez, S.Pacilè, P. FIllard (2021, April 9-11). Potential Benefits of an AI System in the Early Detection of Breast Cancer. [conference presentation]. SBI 2021
Radiologists can read an additional 700+
screenings per month on average with the use of
MammoScreen for tomosynthesis.
Through the use of MammoScreen, radiologists
can read screenings faster during batch readings.
Radiologists assisted by MammoScreen read an
additional 13% of cases per hour. In a healthcare
system that reads approximately 250,000 screenings
per year, the use of MammoScreen could save 2,850
hours of radiologist time, which is a savings of almost
0.5 FTE!*
You are the expert, but we are here to help.
Even the most accomplished authors still use
spellcheck to help assist them. Radiologists can
have the added confidence that MammoScreen
is there to help reassure them, or alert them to
certain areas of concern. MammoScreen provides a
reliable score for every mammogram that helps you
to identify the cases that need the most attention.
Unlike humans, MammoScreen has no bias, does not
get fatigued, and cannot be overworked.
With our unique MammoScreen Score, we help
radiologists focus on those tough cases and have
confidence to move quickly on the easier ones
*S.Pacilè, P. FIllard (2021, Nov 28 - Dec 2). Artificial Intelligence for Digital Breast Tomosynthesis a tool to enhance performance effectiveness
[conference poster]. RSNA 2021
Two heads are better than one. The old saying rings
true in radiology as well. With 75% of cases in our green
score, you can have confidence that there is low, if not
the lowest risk of cancer. Conversely, 5% of all cases
are categorized in the red section, MammoScreen is
confident that there is a strong suspicion. The other
20% of cases are yellow, those cases are of concern,
and your expertise is required to classify them.
The use of MammoScreen can help
you find up to 50% of missed cancers*
Requires no additional equipment or investment.
Completely remote installation that can be up
and running same-day
Works with any existing infrastructure vendor
We recognize that not all radiologists work the same
way. MammoScreen has features that can be turned
on or off depending on your preferences:
• Markings and indicators can be toggled on and off
for green cases
• By default, we are on a separate monitor to avoid
‘screen pollution’
• Possibilities are endless, we are here to accelerate,
not disrupt your workflow.
*S.Pacilè, P. FIllard (2021, Nov 28 - Dec 2). Artificial Intelligence for Digital Breast Tomosynthesis a tool to enhance performance effectiveness
[conference poster]. RSNA 2021
Schedule your demo online at: MammoScreen.com/demo
1700 W Irving Park Road ST. 302 www.mammoscreen.com MammoScreen ® is a registered
Chicago - IL 60613 USA
[email protected] trademark of Therapixel Inc
Manufacturer: Therapixel SA Copyright Therapixel © 2022
TPX-MS-COM-2022 MAMMOSCREEN BROCHURE_US_2022-MAY-10
